AchE Inhibitor and Insulin

Summary

AchE Inhibitor and Insulin is a clinical trial^[1].

Key Facts

• AchE Inhibitor and Insulin is in the country of United States^[2].
• AchE Inhibitor and Insulin's instance of is recorded as clinical trial^[3].
• AchE Inhibitor and Insulin's start time is recorded as +2017-04-19T00:00:00Z^[4].
• AchE Inhibitor and Insulin's end time is recorded as +2018-12-14T00:00:00Z^[5].
• AchE Inhibitor and Insulin's sponsor is recorded as University of Miami^[6].
• AchE Inhibitor and Insulin's main subject is recorded as diabetes^[7].
• AchE Inhibitor and Insulin's number of participants is recorded as {'unit': '1', 'amount': '+12'}^[8].
• AchE Inhibitor and Insulin's title is recorded as Using Acetylcholinesterase Inhibitors to Promote Insulin Secretion in Human Beings^[9].
• AchE Inhibitor and Insulin's short name is recorded as AchE^[10].
• AchE Inhibitor and Insulin's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• AchE Inhibitor and Insulin's ClinicalTrials.gov ID is recorded as NCT03063515^[12].
• AchE Inhibitor and Insulin's research intervention is recorded as pyridostigmine bromide^[13].
• AchE Inhibitor and Insulin's clinical trial phase is recorded as phase I clinical trial^[14].
• AchE Inhibitor and Insulin's research subject recruitment status is recorded as completed^[15].
• AchE Inhibitor and Insulin's study type is recorded as interventional study^[16].